MAXBIOPHARMA.COM KEYWORD DENSITY CHECKER

Total words: 800 | 2-word phrases: 207 | 3-word phrases: 222 | 4-word phrases: 223

PAGE INFO

Title Try to keep the title under 60 characters (28 characters)
Home - ::: MAX BioPharma :::
Description Try to keep the meta description between 50 - 160 characters (141 characters)
MAX BioPharma is a California-based biopharmaceutical company developing novel small molecule lipids as drug candidates for human diseases...
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (31 characters)
BETTER HEALTH FOR BETTER FUTURE

ONE WORD PHRASES 148 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1our96.08%
2follow74.73%
3and53.38%
4company42.70%
5of42.70%
6us42.70%
7for42.70%
8primary32.03%
9the32.03%
10as32.03%

TWO WORD PHRASES 207 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1primary focus31.45%
2follow follow31.45%
3our company20.97%
4drug candidate20.97%
5view details20.97%
6our primary20.97%
7oxysterol therapeutics®20.97%
8human diseases20.97%
9is a20.97%
10our team20.97%
11website preloader20.97%
12about us20.97%
13max biopharma20.97%
14us our10.48%
15and antiinflammatory10.48%
16oxy210 an10.48%
17an orally10.48%
18orally bioavailable10.48%
19oxysterolbased drug10.48%
20investor relations10.48%

THREE WORD PHRASES 222 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1our primary focus20.90%
2follow follow follow20.90%
3nashmash oxy210 an10.45%
4stimulates bone formation10.45%
5bone formation by10.45%
6formation by targeting10.45%
7by targeting specialized10.45%
8targeting specialized stem10.45%
9cells view details10.45%
10view details nashmash10.45%
11details nashmash oxy21010.45%
12oxy210 an orally10.45%
13device that stimulates10.45%
14an orally bioavailable10.45%
15oxysterolbased drug candidate10.45%
16drug candidate with10.45%
17candidate with antifibrotic10.45%
18with antifibrotic and10.45%
19antifibrotic and antiinflammatory10.45%
20properties is being10.45%
21is being developed10.45%
22being developed as10.45%
23that stimulates bone10.45%
24an oxysterolbased osteoinductive10.45%
25oxysterolbased osteoinductive investigational10.45%
26preloader investor relations10.45%
27lead to treatments10.45%
28to treatments for10.45%
29numerous indications our10.45%
30indications our mission10.45%

FOUR WORD PHRASES 223 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1website preloader investor relations10.45%
2cells view details nashmash10.45%
3is an oxysterolbased osteoinductive10.45%
4an oxysterolbased osteoinductive investigational10.45%
5device that stimulates bone10.45%
6that stimulates bone formation10.45%
7stimulates bone formation by10.45%
8bone formation by targeting10.45%
9formation by targeting specialized10.45%
10by targeting specialized stem10.45%
11view details nashmash oxy21010.45%
12focus areas spine fusion10.45%
13details nashmash oxy210 an10.45%
14nashmash oxy210 an orally10.45%
15oxy210 an orally bioavailable10.45%
16oxysterolbased drug candidate with10.45%
17drug candidate with antifibrotic10.45%
18candidate with antifibrotic and10.45%
19with antifibrotic and antiinflammatory10.45%
20properties is being developed10.45%
21oxyfuse133® is an oxysterolbased10.45%
22primary focus areas spine10.45%
23being developed as a10.45%
24our mission revolutionize the10.45%
25intellectual property portfolio that10.45%
26property portfolio that will10.45%
27portfolio that will lead10.45%
28that will lead to10.45%
29will lead to treatments10.45%
30lead to treatments for10.45%
31numerous indications our mission10.45%
32indications our mission revolutionize10.45%
33mission revolutionize the way10.45%
34our primary focus areas10.45%
35revolutionize the way we10.45%
36the way we attack10.45%
37preloader investor relations contact10.45%
38serious human diseases learn10.45%
39human diseases learn more10.45%
40diseases learn more our10.45%

EXTERNAL LINKS

# URL Whois Check